Company

Regnum Corp

Headquarters: San Francisco, CA, United States

Employees: 2

CEO: Ms. Anne Kirby

OTC: RGMP

Market Cap

$135,405

USD as of Jan. 1, 2024

Market Cap History

Regnum Corp market capitalization over time

Evolution of Regnum Corp market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Regnum Corp

Detailed Description

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a CCR5 antagonist to treat multi-drug resistant HIV infection. The company is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Regnum Corp has the following listings and related stock indices.


Stock: OTC: RGMP wb_incandescent

Details

Headquarters:

765 Beach Street

Suite 200

San Francisco, CA 94109

United States

Phone: 844 496 6539